MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

September 6, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

March 31, 2015

Conditions

Spasticity, Muscle

Interventions

DRUG

Meditoxin

Meditoxin® (Botulinum toxin type A) was injected up to 360 U.

All Listed Sponsors

lead

Medy-Tox

INDUSTRY

NCT03908580 - MEDITOXIN® Treatment in Subjects With Post-Stroke Upper Limb Spasticity | Biotech Hunter | Biotech Hunter